| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Adam H Schechter | President Ceo | 80,773 | 0 | 05 Mar, 2026 |
| Glenn A Eisenberg | Executive Vice President | 37,920 | 0 | 31 Mar, 2025 |
| Brian J Caveney | Evp, Pres Of Ed, Cmo Cso | 30,107 | 0 | 26 Feb, 2026 |
| Lance Berberian | Evp, Special Advisor, Strategy | 18,652 | 0 | 31 Mar, 2025 |
| Jean-Luc Belingard | 17,781 | 0 | 08 Feb, 2024 | |
| Peter M Neupert | 13,784 | 0 | 13 Feb, 2026 | |
| Garheng Kong | 13,739 | 0 | 13 Feb, 2026 | |
| Paul R Kirchgraber | Ceo, Covance Drug Development | 12,946 | 0 | 23 May, 2023 |
| Kerrii B Anderson | 9,563 | 0 | 13 Feb, 2026 | |
| R Sanders Williams | 8,120 | 0 | 08 Feb, 2024 | |
| Dwight Gary Gilliland | 6,656 | 0 | 01 Aug, 2025 | |
| Mark S Schroeder | Evp, Pres Diagnostics Coo | 6,473 | 0 | 13 Feb, 2026 |
| Amy B. Summy | Evp, Chief Marketing Officer | 5,722 | 0 | 13 Feb, 2026 |
| Bryan T Vaughn | Evp, Diagnostics | 5,613 | 0 | 13 Feb, 2026 |
| Jonathan P. Divincenzo | Evp, Pres, Central Labs Intl | 5,461 | 0 | 29 Mar, 2024 |
| Jeffrey A. Davis | 5,460 | 0 | 13 Feb, 2026 | |
| Judith C Seltz | Evp, Chro | 4,182 | 0 | 03 Apr, 2023 |
| Megan D. Bailey | Evp, Pres, Central Labs Intl | 4,148 | 0 | 13 Feb, 2026 |
| Kathryn E Wengel | 4,133 | 0 | 13 Feb, 2026 | |
| Akinbolade Oyegunwa | Evp, Cio Cto | 4,106 | 0 | 13 Feb, 2026 |
| Kathryn W Kyle | Evp, Chief Legal Officer | 3,442 | 0 | 13 Feb, 2026 |
| Richelle P Parham | 3,366 | 0 | 13 Feb, 2026 | |
| Kirsten Marie Kliphouse | 3,160 | 0 | 13 Feb, 2026 | |
| Jonathan C Meltzer | Evp, Operations | 2,782 | 0 | 13 Feb, 2026 |
| Der Vaart Sandra D Van | Evp, Corporate Affairs | 2,579 | 0 | 03 Mar, 2026 |
| Paul Rothman | 2,571 | 0 | 13 Feb, 2026 | |
| Peter J Wilkinson | Svp, Chief Accounting Officer | 1,852 | 0 | 23 Feb, 2026 |
| Julia Aijun Wang | Chief Financial Officer, Evp | 1,817 | 0 | 13 Feb, 2026 |
| Anita Z Graham | Evp, Chro | 1,460 | 0 | 13 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Mar, 2026 | Adam H Schechter | Common Stock | D | 8,705 | $279.96 | 80,773 | D | S |
| 27 Feb, 2026 | Der Vaart Sandra D Van | Common Stock | D | 548 | $284.91 | 2,579 | D | S |
| 24 Feb, 2026 | Brian J Caveney | Common Stock | D | 1,500 | $286.31 | 30,107 | D | S |
| 19 Feb, 2026 | Peter J Wilkinson | Common Stock | D | 666 | $277.94 | 1,852 | D | S |
| 11 Feb, 2026 | Paul Rothman | Common Stock | A | 897 | - | 2,571 | D | M |
| 11 Feb, 2026 | Amy B. Summy | Common Stock | A | 230 | - | 5,805 | D | M |
| 11 Feb, 2026 | Garheng Kong | Common Stock | A | 897 | - | 13,739 | D | M |
| 11 Feb, 2026 | Kerrii B Anderson | Common Stock | A | 897 | - | 9,563 | D | M |
| 11 Feb, 2026 | Kathryn E Wengel | Common Stock | A | 897 | - | 4,133 | D | M |
| 11 Feb, 2026 | Mark S Schroeder | Common Stock | A | 806 | - | 6,732 | D | M |
| 11 Feb, 2026 | Adam H Schechter | Common Stock | D | 5,273 | $284.38 | 87,343 | D | S |
| 11 Feb, 2026 | Akinbolade Oyegunwa | Common Stock | A | 230 | - | 4,174 | D | M |
| 11 Feb, 2026 | Der Vaart Sandra D Van | Common Stock | A | 376 | - | 3,225 | D | M |
| 11 Feb, 2026 | Peter J Wilkinson | Common Stock | A | 536 | - | 2,564 | D | M |
| 11 Feb, 2026 | Richelle P Parham | Common Stock | A | 897 | - | 3,366 | D | M |
| 11 Feb, 2026 | Peter M Neupert | Common Stock | A | 897 | - | 13,784 | D | M |
| 11 Feb, 2026 | Julia Aijun Wang | Common Stock | A | 860 | - | 2,062 | D | M |
| 11 Feb, 2026 | Bryan T Vaughn | Common Stock | A | 323 | - | 5,706 | D | M |
| 11 Feb, 2026 | Anita Z Graham | Common Stock | A | 356 | - | 1,569 | D | M |
| 11 Feb, 2026 | Jonathan C Meltzer | Common Stock | A | 243 | - | 2,939 | D | M |